You are here

  • Home
  • Archive
  • Volume 78, Issue 6
  • Validity of the Swedish version of the systemic sclerosis quality of life questionnaire (SSCQoL): A novel measure of quality of life for patients with systemic sclerosis

Article Text

Article menu
Download PDFPDF
Letter
Validity of the Swedish version of the systemic sclerosis quality of life questionnaire (SSCQoL): A novel measure of quality of life for patients with systemic sclerosis
  1. Gunnel Sandqvist,
  2. Roger Hesselstrand
  1. Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden
  1. Correspondence to Dr Gunnel Sandqvist, Department of Rheumatology, Skåne University Hospital, Lund SE-221 85, Sweden; gunnel.sandqvist{at}med.lu.se

http://dx.doi.org/10.1136/annrheumdis-2018-214260

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Systemic sclerosis (SSc) is an autoimmune disease characterised by microvascular injury and excessive fibrosis of the skin and internal organs,1 which influences activities of daily life2 and quality of life (QoL).3 The Medical Outcome Study Short Form-36, the EuroQol-5 Domain (EQ-5D) and the Patient-Reported Outcomes Measurement Information System 29-item are generic health-related QoL instruments, valid to be used in SSc.4 However, disease-specific tools could be more sensitive to capture disease-related factors influencing QoL. The Systemic Sclerosis Quality of Life Questionnaire (SScQoL), developed by Reay5 using a needs-based QoL model, is an outcome for assessing disease impact on health and well-being. The SScQoL consists of 29 items, covering the themes: function, emotion, sleep, social and pain. Each item with ‘yes’‘no’ response options are scored 1 and 0, respectively. The SScQoL has been sufficiently translated …

    View Full Text

    Footnotes

    • Handling editor Josef S Smolen

    • Contributors Both authors contributed equally to this letter.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; externally peer reviewed.